Effects of Recombinant Human Erythropoietin on Platelet Function in Patients With Acute Myocardial Infarction
Status:
Completed
Trial end date:
2008-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to see if a naturally-occurring hormone called erythropoietin
changes the action of platelets in the blood. Patients with heart attacks are treated with
medicines to reduce the clotting action of platelets. This study is trying to determine
whether erythropoietin alters the clotting action of platelets in patients receiving
anti-platelet medicines. It is important to understand the effects of erythropoietin on
platelets since preliminary studies in animals suggest that erythropoietin may protect the
heart from damage during a heart attack.